This is invited editorial based on the original research paper for which M. Noč served as an reviewer.
This is a substudy of EGYPT cooperation group investigating benefits of GP llb/llla (Abciximab) in the setting of STEMI and primary PCI.
This was an invited publication by the editorial board. We published a review paper on aboev topics and described our treatment startegy.